Search Results - "Gray, K. P."

Refine Results
  1. 1

    PD-L1 expression in nonclear-cell renal cell carcinoma by Choueiri, T.K., Fay, A.P., Gray, K.P., Callea, M., Ho, T.H., Albiges, L., Bellmunt, J., Song, J., Carvo, I., Lampron, M., Stanton, M.L., Hodi, F.S., McDermott, D.F., Atkins, M.B., Freeman, G.J., Hirsch, M.S., Signoretti, S.

    Published in Annals of oncology (01-11-2014)
    “…Programmed death ligand-1 (PD-L1) expression in nonclear-cell RCC (non-ccRCC) and its association with clinical outcomes are unknown. Formalin-fixed…”
    Get full text
    Journal Article
  2. 2

    Secretory leukocyte protease inhibitor is a survival and proliferation factor for castration-resistant prostate cancer by Zheng, D, Gui, B, Gray, K P, Tinay, I, Rafiei, S, Huang, Q, Sweeney, C J, Kibel, A S, Jia, L

    Published in Oncogene (08-09-2016)
    “…Androgen receptor (AR)-mediated gene expression continues to have a critical role in promoting castration-resistant prostate cancer (CRPC) survival and growth…”
    Get full text
    Journal Article
  3. 3

    A meta-analysis of patient outcomes with subcentimeter disease after chemotherapy for metastatic non-seminomatous germ cell tumor by Ravi, P., Gray, K.P., O'Donnell, E.K., Sweeney, C.J.

    Published in Annals of oncology (01-02-2014)
    “…Approximately a quarter of men with metastatic non-seminomatous germ cell tumor (NSGCT) have a residual mass, typically in the retroperitoneum, after…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Risk of prostate cancer‐specific death in men with baseline metabolic aberrations treated with androgen deprivation therapy for biochemical recurrence by Rudman, Sarah M., Gray, Kathryn P., Batista, Julie L., Pitt, Michael J., Giovannucci, Edward L., Harper, Peter G., Loda, Massimo, Mucci, Lorelei A., Sweeney, Christopher J.

    Published in BJU international (01-12-2016)
    “…Objectives To investigate the associations of host metabolic factors and metabolic syndrome on prostate cancer‐specific death (PCSD) and overall survival (OS)…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Abstract P3-07-36: Immune related gene expression signatures predict benefit of letrozole over tamoxifen in BIG 1-98 by Willis, S, Gray, KP, Regan, MM, Rae, JM, Kammler, R, Young, B, Ditzel, HJ, Lyng, MB, Colleoni, M, Viale, G, Leyland-Jones, B

    Published in Cancer research (Chicago, Ill.) (15-02-2016)
    “…Background: The prognostic significance of increased levels of CD8+ tumor infiltrating lymphocytes(TILs) in ER- breast cancer has been described. We sought to…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    A 155 Mbit/s FEC codec for satellite B-ISDN by Morrison, I.S., Pietrobon, S.S., Gray, P.K., Kasparian, J.J.

    “…The Centre was awarded a contract with the International Telecommunications Satellite Organisation (INTELSAT) for the development of a codec to support…”
    Get full text
    Conference Proceeding
  18. 18
  19. 19
  20. 20